Morgan Stanley lowered the firm’s price target on Aperam (APEMY) to EUR 28.60 from EUR 29.60 and keeps an Equal Weight rating on the shares. Stainless earnings “remain lackluster,” says the analyst, who lowers 2025 estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY: